Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons

American Journal of Epidemiology

Volumn 141, Issue 6, 1995, Pages 539-545

  Smalley, Walter E ^a   Ray, Wayne A ^a   Daugherty, James R ^a   Griffin, Marie R ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Anti inflammatory agents, non steroldal; Cohort studies; Gastrointestinal hemorrhage; Medicaid; Peptic ulcer

Indexed keywords

ANTICOAGULANT AGENT; FENOPROFEN; IBUPROFEN; INDOMETACIN; MECLOFENAMIC ACID; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; SULINDAC; TOLMETIN;

AGED; ARTICLE; DUODENUM ULCER; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; OSTEOARTHRITIS; PEPTIC ULCER; STOMACH ULCER;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DUODENAL ULCER; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITALIZATION; HUMAN; INCIDENCE; MALE; MEDICAID; MEDICAL RECORDS; OSTEOARTHRITIS; POISSON DISTRIBUTION; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEX FACTORS; STOMACH ULCER; SUPPORT, U.S. GOV'T, P.H.S.; TENNESSEE; UNITED STATES;

EID: 0028932488     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a117469     Document Type: Article

References (39)

1. Tomita DK, Baum C, Kennedy DL, et al. Drug utilization in the United States-1987, ninth annual review. Washington, DC: Department of Health and Human Services, 1988. (DHHS publication no. PB89-143325).
2. Tomita DK, Kennedy DL, Baum C, et al. Drug utilization in the United States-1988, tenth annual review. Washington, DC: Department of Health and Human Services, 1988. (DHHS publication no. PB90-15921).
3. Burke LB, Baum C, Jolson HM, et al. Drug utilization in the United States-1989, eleventh annual review. Washington, DC: Department of Health and Human Services, 1991. (DHHS publication no. PB91-198838).
4. Griffin MR, Ray WA, Schaffner W. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med 1988;109:359-63.
5. Griffin MR, Piper JM, Daugherty JR, et al. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991;114:257-63.
6. Somerville K, Faulkner G, Langmen M. Nonsteroidal antiinflammatory drugs and bleeding peptic ulcer. Lancet 1986; 1:462-4.
7. Chrischilles EA, Lemke JH, Wallace RB, et al. Prevalence and characteristics of multiple analgesic drug use in an elderly study group. J Am Genatr Soc 1990;38:979-84.
8. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1991;115:787-96.
9. Beardon PHG, Brown SV, McDevitt DG. Gastrointestinal events in patients prescribed nonsteroidal anti-inflammatory drugs: a controlled study using record linkage in Tayside. Q J Med 1989;266:497-505.
10. Beard K, Walker AM, Perera DR, et al. Nonsteroidal antiinflammatory drugs and hospitalization for gastroesophageal bleeding in the elderly. Arch Intern Med 1987;147:1621-3.
11. Guess HA, West R, Strand LM, et al. Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983. J Clin Epidemiol 1988;41:35-45.
12. Garcia Rodriguez LA, Walker AM, Gutthann SP. Nonsteroidal antiinflammatory drugs and gastrointestinal hospitalizations in Saskatchewan: a cohort study. Epidemiology 1992;3: 337-42.
13. Henry D, Dobson A, Turner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 1993;105:1078-88.
14. Jick SS, Perera DR, Walker AM, et al. Nonsteroidal antiinflammatory drugs and perforated peptic ulcer. (Letter). Lancet 1987;2:I398.
15. Carson JL, Strom BL, Soper KA, et al. The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Mod 1987;147:85-8.
16. Fries JF, Miller SR, Spitz PW, et al. Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use. Gastroenterology 1989;96:647-55.
17. Jones AC, Berman P, Doherty M. Non-steroidal antiinflammatory drug usage and requirement in elderly acute hospital admissions. Br J Rheumatol 1992;31:45-8.
18. Amadio P Jr, Cummings DM. Evaluation of acetaminophen in the management of osteoarthritis of the knee. Curr Ther Res 1983;34:59-66.
19. Bradley JD, Brandt KD, Katz BP, et al. Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991;325:87-91.
20. Kovar PA, Allegrante JP, MacKenzie CR, et al. Supervised fitness walking in patients with osteoarthritis of the knee. A randomized, controlled trial. Ann Intern Med 1992; 116: 529-34.
21. Felson DT, Zhang Y, Anthony JM, et al. Weight loss reduces the risk for symptomatic knee osteoarthritis in women. Ann Intern Med 1992;116:535-9.
22. Graham DY, Agrawal NM, Roth SH. Prevention of NSAID- induced gastric ulcer with misoprostol: multicentre, doubleblind, placebo-controlled trial. Lancet 1988;2:1277-80.
23. Edelson JT, Tosteson ANA, Sax P. Cost-effectiveness of misoprostol for prophylaxis against nonsteroidal antiinflammatory drug-induced gastrointestinal tract bleeding. JAMA 1990;264:41-7.
24. Hillman AL, Bloom BS. Economic effects of prophylactic use of misoprostol to prevent gastric ulcer in patients taking nonsteroidal anti-inflammatory drugs. Arch Intern Med 1989; 149: 2061-5.
25. US Department of Health and Human Services. International Classification of Diseases, 9th Revision, Clinical Modification. 2nd ed. Washington, DC: US GPO, 1980.
26. Anonymous. Drugs for rheumatoid arthritis. Med Lett Drugs Ther 1993;33:65-70.
27. McCullagh P, Neider JA. Generalized linear models. 2nd ed. New York, NY: Chapman and Hall, 1989:193-208.
28. Wilcosky TC, Chambless LE. A comparison of direct adjustment and regression adjustment of epidemiologic measures. J Chronic Dis 1985;10:849-56.
29. Kleinbaum DG, Küpper LL, Morgenstern H. Epidemiologie research principles and quantitative methods. New York, NY: Van Nostrand Reinhold Co., Inc., 1982:1-529.
30. Lessler JT, Harris BSH. Medicaid data as a source of postmarketing surveillance information. Final report. Vol. 1. Technical report Research Triangle Park, NC: Research Triangle Institute, 1984.
31. Landry JA, Smyer MA. Home visit medicine use validation study. In: Anonymous. Medicine, health, and aging: enrollment in Pennsylvania’s Pharmaceutical Assistance Contract for the Elderly (PACE) Program. Philadelphia, PA: The Pennsylvania State University, 1986:1-37.
32. Leister KA, Edwards WA, Christensen DB, et al. A comparison of patient drug regimens as viewed by the physician, pharmacist and patient. Med Care 1981;19:658-64.
33. Graves EJ, Kozak LJ. National hospital discharge survey: annual summary, 1990. Hyattsville, MD: National Center for Health Statistics, 1992. (Vital and health statistics, Series 13: No. 112). (DHHS publication no. (PHS) 92-1773).
34. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323:1505-11.
35. Stroke prevention in atrial fibrillation investigators. Stroke prevention in atrial fibrillation study: final results. Circulation 1991;84:527-39.
36. Kutner M, Nixon G, Silverstone F. Physicians’ attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation. Arch Intern Med 1991;151:1950-3.
37. Calin A. Pain and inflammation. Am J Med 1984; 77(Suppl.3A):9-15.
38. Shorr RI, Ray WA, Daugherty JR, et al. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. Arch Intern Med 1993;153:1665-70.
39. Piper JM, Ray WA, Daugherty JR, et al. Corticosteroid use and peptic ulcer disease: role of nonsteroidal antiinflammatory drugs. Ann Intern Med 1991;114:735-40.